CIK 0001711279
- Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 821080209
- Phone
- +1 412-586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- 4 Shares withheld for taxes President, R&D gave up 43,877 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 43,877 shares (to pay taxes)
- 4 Planned sale President, R&D sold 50,000 shares at an average $164.80 ($8,240,023)
- 4 Planned sale President and CEO sold 50,000 shares at an average $164.80 ($8,240,023)
- 4 Planned sale President, R&D sold 50,000 shares at an average $197.77 ($9,888,276)
- 4 Planned sale President and CEO sold 50,000 shares at an average $197.77 ($9,888,276)
- 4 Gift Director gave 5,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale President, R&D sold 50,000 shares at an average $175.76 ($8,788,062)
- 4 Planned sale President and CEO sold 50,000 shares at an average $175.76 ($8,788,062)
- 4 Open-market sale Director sold 20,000 shares at an average $164.13 ($3,282,690)
- 4 Planned sale President, R&D sold 50,000 shares at an average $170.95 ($8,547,719)
- 4 Planned sale President and CEO sold 50,000 shares at an average $170.95 ($8,547,719)
- 4 Planned sale Chief Accounting Officer sold 5,000 shares at an average $165.88 ($829,417)
- 4 Planned sale Chief Accounting Officer sold 7,500 shares at an average $166.05 ($1,245,381)
Page 3 of 10 · 186 filings